These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16089355)

  • 1. Assessment of modes of action and efficacy of plasma cholesterol-lowering drugs: measurement of cholesterol absorption, cholesterol synthesis and bile acid synthesis and turnover using novel stable isotope techniques.
    Stellaard F; Kuipers F
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Jun; 5(2):209-18. PubMed ID: 16089355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects.
    Gylling H; Miettinen TA
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):19-23. PubMed ID: 12125225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of surrogate markers to monitor cholesterol absorption, synthesis and bioconversion to bile acids under lipid lowering therapies.
    Stellaard F; von Bergmann K; Sudhop T; Lütjohann D
    J Steroid Biochem Mol Biol; 2017 May; 169():111-122. PubMed ID: 27060336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol absorption inhibitors as a therapeutic option for hypercholesterolaemia.
    Burnett JR; Huff MW
    Expert Opin Investig Drugs; 2006 Nov; 15(11):1337-51. PubMed ID: 17040195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid lowering activity of drugs affecting cholesterol absorption.
    Norata GD; Catapano AL
    Nutr Metab Cardiovasc Dis; 2004 Feb; 14(1):42-51. PubMed ID: 15053163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barley β-glucan reduces blood cholesterol levels via interrupting bile acid metabolism.
    Wang Y; Harding SV; Thandapilly SJ; Tosh SM; Jones PJH; Ames NP
    Br J Nutr; 2017 Nov; 118(10):822-829. PubMed ID: 29115200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cholesterol metabolism and therapeutic molecules.
    Charlton-Menys V; Durrington PN
    Exp Physiol; 2008 Jan; 93(1):27-42. PubMed ID: 18165431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cholesterol metabolism modulators in future drug therapy for atherosclerosis].
    Morozova S; Suc-Royer I; Auwerx J
    Med Sci (Paris); 2005 Dec; 21 Spec No():53-8. PubMed ID: 16598906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced cholesterol absorption in hamsters by crilvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Hajri T; Chanussot F; Férézou J; Riottot M; Lafont H; Laruelle C; Lutton C
    Eur J Pharmacol; 1997 Feb; 320(1):65-71. PubMed ID: 9049604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary cholesterol, cholesterol absorption, postprandial lipemia and atherosclerosis.
    Huff MW
    Can J Clin Pharmacol; 2003; 10 Suppl A():26A-32A. PubMed ID: 14571303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plant stanol fatty acid esters inhibit cholesterol absorption and hepatic hydroxymethyl glutaryl coenzyme A reductase activity to reduce plasma levels in rabbits.
    Xu G; Salen G; Shefer S; Tint GS; Nguyen LB; Batta AK; Pcolinsky M
    Metabolism; 2001 Sep; 50(9):1106-12. PubMed ID: 11555847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New therapies on the horizon.
    Brown WV
    Am J Manag Care; 2001 May; 7(5 Suppl):S148-51. PubMed ID: 11383377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol absorption inhibitors in development as potential therapeutics.
    Kajinami K; Takekoshi N
    Expert Opin Investig Drugs; 2002 Jun; 11(6):831-5. PubMed ID: 12036426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanisms of and the interrelationship between bile acid and chylomicron-mediated regulation of hepatic cholesterol synthesis in the liver of the rat.
    Nervi FO; Dietschy JM
    J Clin Invest; 1978 Apr; 61(4):895-909. PubMed ID: 566279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
    Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
    Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hypocholesterolemic activity of Momordica charantia fruit is mediated by the altered cholesterol- and bile acid-regulating gene expression in rat liver.
    Matsui S; Yamane T; Takita T; Oishi Y; Kobayashi-Hattori K
    Nutr Res; 2013 Jul; 33(7):580-5. PubMed ID: 23827133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Change in the cholesterol metabolism associated with the combined inhibition of synthesis and absorption].
    Márk L; Paragh G
    Orv Hetil; 2007 Apr; 148(14):627-32. PubMed ID: 17403635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ursodeoxycholic acid on cholesterol absorption and metabolism in humans.
    Woollett LA; Buckley DD; Yao L; Jones PJ; Granholm NA; Tolley EA; Heubi JE
    J Lipid Res; 2003 May; 44(5):935-42. PubMed ID: 12611908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting cholesterol absorption with CP-88,818 (beta-tigogenin cellobioside; tiqueside): studies in normal and hyperlipidemic subjects.
    Harris WS; Dujovne CA; Windsor SL; Gerrond LL; Newton FA; Gelfand RA
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):55-60. PubMed ID: 9268221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular aspects of hypercholesterolemia treatment: current perspectives and hopes.
    Ahangari N; Ghayour Mobarhan M; Sahebkar A; Pasdar A
    Ann Med; 2018 Jun; 50(4):303-311. PubMed ID: 29578362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.